Two Seas Capital Reduces Stake in Core Scientific, Falls Below 5% Ownership
Summary
Institutional investor Two Seas Capital has significantly reduced its stake in Core Scientific, selling approximately $71.7 million in shares and dropping below 5% beneficial ownership.
Key Events
-
Significant Stake Reduction
Two Seas Capital LP, along with its affiliates, reported a reduction in beneficial ownership of Core Scientific, Inc. to 4.4% of outstanding common stock, down from 5.0% previously. This means they are no longer a 5% owner.
-
Substantial Share Sales
Since April 16, 2026, the reporting persons executed net sales of approximately 3.1 million shares of common stock, totaling approximately $71.7 million. These transactions occurred at weighted average prices ranging from $19.737 to $21.55 per share.
-
Timing with Debt Offering
This divestment by a major institutional investor follows closely on the heels of Core Scientific's indirect subsidiary announcing a proposed $3.3 billion senior secured notes offering on April 21, 2026.
Analysis
Two Seas Capital LP, a significant institutional investor, has reduced its beneficial ownership in Core Scientific, Inc. to 4.4%, falling below the 5% threshold. This reduction follows a series of net sales totaling approximately $71.7 million since April 16, 2026. The timing of this divestment is notable as it occurs shortly after Core Scientific's indirect subsidiary announced a proposed $3.3 billion senior secured notes offering, potentially signaling a re-evaluation of the investment thesis by Two Seas Capital in light of the company's recent financing activities.
At the time of this filing, CORZ was trading at $21.15 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $7.06 to $23.63. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.